XML 126 R108.htm IDEA: XBRL DOCUMENT v3.6.0.2
Guarantor Financial Information Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2016
Oct. 01, 2016
Jul. 02, 2016
Apr. 02, 2016
Jan. 02, 2016
Oct. 03, 2015
Jul. 04, 2015
Apr. 04, 2015
Dec. 31, 2016
Jan. 02, 2016
Jan. 03, 2015
Net income $ 41,680 $ 28,890 $ 33,991 $ 2,663 $ 85,875 $ (7,357) $ 4,937 $ 1,824 $ 107,224 $ 85,279 $ 68,311
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 283,812 335,680 206,861
Net cash provided by operating activities                 391,036 420,959 275,172
Cash flows from investing activities:                      
Capital expenditures [1]                 (243,523) (229,848) (228,918)
Acquisitions, net of cash acquired                 (8,511) (377) (2,094,400)
Investment in unconsolidated subsidiary                 0 0 0
Note receivable from affiliates                 0 0 0
Gross proceeds from sale of property, plant and equipment and other assets                 7,329 3,840 9,262
Proceeds from insurance settlement                 1,537 561 1,550
Payments related to routes and other intangibles                 (23) (3,845) (11,288)
Net cash used in investing activities                 (243,191) (229,669) (2,323,794)
Cash flows from financing activities:                      
Proceeds from long-term debt                 36,327 590,745 1,842,184
Payments on long-term debt                 (204,428) (609,255) (333,762)
Borrowings from revolving credit facility                 99,276 78,244 170,143
Payments on revolving credit facility                 (104,028) (166,755) (351,589)
Net cash overdraft financing                 1,071 (1,261) 4,077
Deferred loan costs                 (3,879) (17,310) (45,223)
Issuance of common stock                 188 171 416
Repurchase of treasury stock                 (5,000) (5,912) 0
Contributions from parent                 0 0 0
Minimum withholding taxes paid on stock awards                 (1,843) (4,874) (10,026)
Excess tax benefit from stock-based compensation                 0 0 2,420
Addition/(deductions) of noncontrolling interest                 0 (87) 1,201
Distributions to noncontrolling interests                 (1,552) (3,295) (4,272)
Net cash provided/(used) in financing activities                 (183,868) (139,589) 1,275,569
Effect of exchange rate changes on cash flows                 (6,297) (3,601) 10,980
Net increase/(decrease) in cash and cash equivalents                 (42,320) 48,100 (762,073)
Cash and cash equivalents at beginning of year       156,884       108,784 156,884 108,784 870,857
Cash and cash equivalents at end of year 114,564       156,884       114,564 156,884 108,784
Issuer [Member]                      
Net income                 107,224 85,279 68,311
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 (223,347) (198,371) (223,790)
Other operating cash flows                 317,040 250,597 226,120
Net cash provided by operating activities                 200,917 137,505 70,641
Cash flows from investing activities:                      
Capital expenditures                 (51,330) (46,574) (39,248)
Acquisitions, net of cash acquired                 0 0 0
Investment in unconsolidated subsidiary                 0 (20) (1,483,007)
Note receivable from affiliates                 0 0 0
Gross proceeds from sale of property, plant and equipment and other assets                 2,784 1,035 1,522
Proceeds from insurance settlement                 0 71 1,350
Payments related to routes and other intangibles                 0 0 (9,640)
Net cash used in investing activities                 (48,546) (45,488) (1,529,023)
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 0 1,100,000
Payments on long-term debt                 (143,935) (16,111) (264,500)
Borrowings from revolving credit facility                 94,000 25,000 122,445
Payments on revolving credit facility                 (94,000) (90,000) (297,445)
Net cash overdraft financing                 0 0 0
Deferred loan costs                 (3,879) (7,295) (41,748)
Issuance of common stock                 188 171 416
Repurchase of treasury stock                 (5,000) (5,912)  
Contributions from parent                 0 0 0
Minimum withholding taxes paid on stock awards                 (1,718) (4,874) (10,026)
Excess tax benefit from stock-based compensation                     2,420
Addition/(deductions) of noncontrolling interest                   0 0
Distributions to noncontrolling interests                 0 0 0
Net cash provided/(used) in financing activities                 (154,344) (99,021) 611,562
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 (1,973) (7,004) (846,820)
Cash and cash equivalents at beginning of year       3,443       10,447 3,443 10,447 857,267
Cash and cash equivalents at end of year 1,470       3,443       1,470 3,443 10,447
Guarantors [Member]                      
Net income                 102,699 101,828 155,250
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 (100,970) (53,098) (34,238)
Net cash provided by operating activities                 1,729 48,730 121,012
Cash flows from investing activities:                      
Capital expenditures                 (91,340) (91,702) (84,299)
Acquisitions, net of cash acquired                 0 0 (19,394)
Investment in unconsolidated subsidiary                 (12,754) (45,103) (1,442,788)
Note receivable from affiliates                 103,056 76,019 (204,074)
Gross proceeds from sale of property, plant and equipment and other assets                 1,070 1,154 5,155
Proceeds from insurance settlement                 0 490 200
Payments related to routes and other intangibles                 0 0 0
Net cash used in investing activities                 32 (59,142) (1,745,200)
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 0 0
Payments on long-term debt                 0 (55) (87)
Borrowings from revolving credit facility                 0 0 0
Payments on revolving credit facility                 0 0 0
Net cash overdraft financing                 0 0 0
Deferred loan costs                 0 0 0
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0 0  
Contributions from parent                 0 0 1,632,618
Minimum withholding taxes paid on stock awards                 0 0 0
Excess tax benefit from stock-based compensation                     0
Addition/(deductions) of noncontrolling interest                   0 0
Distributions to noncontrolling interests                 0 0 0
Net cash provided/(used) in financing activities                 0 (55) 1,632,531
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 1,761 (10,467) 8,343
Cash and cash equivalents at beginning of year       3,993       14,460 3,993 14,460 6,117
Cash and cash equivalents at end of year 5,754       3,993       5,754 3,993 14,460
Non-guarantors [Member]                      
Net income                 120,648 96,543 68,540
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 67,742 138,181 14,979
Net cash provided by operating activities                 188,390 234,724 83,519
Cash flows from investing activities:                      
Capital expenditures                 (100,853) (91,572) (105,371)
Acquisitions, net of cash acquired                 (8,511) (377) (2,075,006)
Investment in unconsolidated subsidiary                 0 29,541 (440,619)
Note receivable from affiliates                 (103,056) (76,019) 204,074
Gross proceeds from sale of property, plant and equipment and other assets                 3,475 1,651 2,585
Proceeds from insurance settlement                 1,537 0 0
Payments related to routes and other intangibles                 (23) (3,845) (1,648)
Net cash used in investing activities                 (207,431) (140,621) (2,415,985)
Cash flows from financing activities:                      
Proceeds from long-term debt                 36,327 590,745 742,184
Payments on long-term debt                 (60,493) (593,089) (69,175)
Borrowings from revolving credit facility                 5,276 53,244 47,698
Payments on revolving credit facility                 (10,028) (76,755) (54,144)
Net cash overdraft financing                 1,071 (1,261) 4,077
Deferred loan costs                 0 (10,015) (3,475)
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0 0  
Contributions from parent                 12,754 15,582 1,733,796
Minimum withholding taxes paid on stock awards                 (125) 0 0
Excess tax benefit from stock-based compensation                     0
Addition/(deductions) of noncontrolling interest                   (87) 1,201
Distributions to noncontrolling interests                 (1,552) (3,295) (4,272)
Net cash provided/(used) in financing activities                 (16,770) (24,931) 2,397,890
Effect of exchange rate changes on cash flows                 (6,297) (3,601) 10,980
Net increase/(decrease) in cash and cash equivalents                 (42,108) 65,571 76,404
Cash and cash equivalents at beginning of year       149,448       83,877 149,448 83,877 7,473
Cash and cash equivalents at end of year 107,340       149,448       107,340 149,448 83,877
Eliminations [Member]                      
Net income                 (223,347) (198,371) (223,790)
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 223,347 198,371 223,790
Other operating cash flows                 0 0 0
Net cash provided by operating activities                 0 0 0
Cash flows from investing activities:                      
Capital expenditures                 0 0 0
Acquisitions, net of cash acquired                 0 0 0
Investment in unconsolidated subsidiary                 12,754 15,582 3,366,414
Note receivable from affiliates                 0 0 0
Gross proceeds from sale of property, plant and equipment and other assets                 0 0 0
Proceeds from insurance settlement                 0 0 0
Payments related to routes and other intangibles                 0 0 0
Net cash used in investing activities                 12,754 15,582 3,366,414
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 0 0
Payments on long-term debt                 0 0 0
Borrowings from revolving credit facility                 0 0 0
Payments on revolving credit facility                 0 0 0
Net cash overdraft financing                 0 0 0
Deferred loan costs                 0 0 0
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0 0  
Contributions from parent                 (12,754) (15,582) (3,366,414)
Minimum withholding taxes paid on stock awards                 0 0 0
Excess tax benefit from stock-based compensation                     0
Addition/(deductions) of noncontrolling interest                   0 0
Distributions to noncontrolling interests                 0 0 0
Net cash provided/(used) in financing activities                 (12,754) (15,582) (3,366,414)
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 0 0 0
Cash and cash equivalents at beginning of year       $ 0       $ 0 0 0 0
Cash and cash equivalents at end of year $ 0       $ 0       $ 0 $ 0 $ 0
[1] Excludes the immaterial capital assets acquired in fiscal 2016 and fiscal 2015 and the VION Acquisition and Custom Blenders acquisition in fiscal 2014 of approximately $984.2 million